Needham & Company LLC Reaffirms “Hold” Rating for Medtronic (NYSE:MDT)

Medtronic (NYSE:MDT – Get Free Report)‘s stock had its “hold” rating restated by Needham & Company LLC in a research note issued to investors on Monday, Benzinga reports. MDT has been the subject of several other reports. Wells Fargo & Company boosted their price objective on Medtronic from $102.00 to $105.00 and gave the company […]

Leave a Reply

Your email address will not be published.

Previous post Leafly (NASDAQ:LFLY) Stock Rating Reaffirmed by Westpark Capital
Next post RioCan Real Estate Investment Trust (TSE:REI.UN) Receives C$20.86 Consensus PT from Analysts